Phase II study of biweekly Gemcitabine and Docetaxel as first line treatment for advanced disease in elderly Non Small Cell Lung Cancer (NSCLC) patients

被引：0
|
作者：
Munoz-Langa, Jose [1 ]
Sanchez-Hernandez, Alfredo [2 ]
Gomez-Codina, Jose [3 ]
Esquerdo, Gaspar [4 ]
Catot, Silvia [5 ]
Macia, Sonia [6 ]
Juan, Oscar [7 ]
Giner, Vicente [8 ]
机构：
[1] Hosp Doctor Peset, Serv Oncol, Valencia, Spain
[2] Hosp Prov Castellon, Castellon de La Plana, Spain
[3] Hosp La Fe, E-46009 Valencia, Spain
[4] Hosp Clin Benidorm, Benidorm, Spain
[5] Hosp Althaia Xarxa Asitencial Manresa, Manresa, Spain
[6] Hosp Elda, Elda, Spain
[7] Hosp Arnau Vilanova, Valencia, Spain
[8] Hosp Sagunto, Sagunto, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2009年 / 4卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S700 / S701
页数：2
相关论文
共 50 条
  • [41] Preliminary results of a multicentre phase II study with gemcitabine monotherapy in the elderly patients with advanced non small cell lung cancer (NSCLC)
    Tibaldi, C
    Ricci, S
    Bonifazi, F
    Fioretto, ML
    Bertuccelli, M
    Petruzzelli, S
    Galli, L
    Antonuzzo, A
    Andrei, A
    Tavanti, L
    Giallombardo, A
    Chiavacci, A
    Pegna, AL
    Conte, PF
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 83 - 83
  • [42] Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer
    Kalmadi, Sujith
    McNeill, Giles
    Davis, Mellar
    Peereboom, David
    Adelstein, David
    Mekhail, Tarek
    [J]. MEDICAL ONCOLOGY, 2006, 23 (04) : 507 - 513
  • [43] Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer
    Sujith Kalmadi
    Giles McNeill
    Mellar Davis
    David Peereboom
    David Adelstein
    Tarek Mekhail
    [J]. Medical Oncology, 2006, 23 : 507 - 513
  • [44] Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer:: a lung cancer Galician group phase II study
    Casal, Joaquin
    Amenedo, Margarita
    Mel, Jose Ramon
    Anton, Luis Miguel
    Rodriguez-Lopez, Ruben
    Lopez-Lopez, Rafael
    Gonzalez-Ageitos, Ana
    Castellanos, Javier
    Constenla, Manuel
    Tisaire, Jose L.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (05) : 725 - 732
  • [45] Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study
    Joaquín Casal
    Margarita Amenedo
    José Ramón Mel
    Luis Miguel Antón
    Rubén Rodríguez-López
    Rafael López-López
    Ana González-Ageitos
    Javier Castellanos
    Manuel Constenla
    José L. Tisaire
    [J]. Cancer Chemotherapy and Pharmacology, 2007, 60 : 725 - 732
  • [46] Biweekly carboplatin and gemcitabine for untreated advanced non-small cell lung cancer (NSCLC). A multicenter phase II trial
    Domine, M
    Gomez, RG
    Firvida, J
    Delgado, J
    Estevez, L
    Docampo, LI
    Leon, A
    Pachon, V
    Casado, V
    Lobo, F
    [J]. LUNG CANCER, 2005, 49 : S242 - S242
  • [47] A PHASE II STUDY OF DOCETAXEL MONOTHERAPY IN SECOND-LINE TREATMENT IN PRETREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Reza, M. S.
    Hai, M. A.
    Chowdhury, Q.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 119 - 120
  • [48] First line treatment of non-small cell lung carcinoma (NSCLC) with docetaxel and vinorelbine: A phase II study
    Kourousis, C
    Androulakis, N
    Kakolyris, S
    Vamvakas, L
    Heras, P
    Metaxaris, G
    Maltezakis, G
    Chalkiadakis, G
    Vlachonikolis, J
    Hatzidaki, D
    Samonis, G
    Georgoulias, V
    [J]. 2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 673 - 679
  • [49] Phase II study of carboplatin combined with biweekly docetaxel for advanced non-small cell lung cancer
    Ishimoto, Osamu
    Sugawara, Shunichi
    Inoue, Akira
    Ishida, Takashi
    Munakata, Mitsuru
    Koinumaru, Sadahiro
    Hasegawa, Yukihiro
    Suzuki, Toshiro
    Miki, Hiroshi
    Saijo, Yasuo
    Nukiwa, Toshihiro
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (09) : 979 - 983
  • [50] Phase II Randomized Study of Vandetanib Plus Gemcitabine or Gemcitabine Plus Placebo as First-Line Treatment of Advanced Non-Small-Cell Lung Cancer in Elderly Patients
    Gridelli, Cesare
    Novello, Silvia
    Zilembo, Nicoletta
    Luciani, Andrea
    Favaretto, Adolfo Gino
    De Marinis, Filippo
    Genestreti, Giovenzio
    Crino, Lucio
    Grossi, Francesco
    Caffo, Orazio
    Ferrau, Francesco
    Cruciani, Giorgio
    Brandes, Alba Ariela
    Galetta, Domenico
    Barni, Sandro
    Fasola, Gianpiero
    Cerea, Giulio
    Ferrari, Silvia
    Iannacone, Claudio
    Ciardiello, Fortunato
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (05) : 733 - 737
12345